Live Breaking News & Updates on Gilde Healthcare

Stay updated with breaking news from Gilde healthcare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy

MedTech industry news ....

United States , Drug Administration , Palette Life Sciences , Memorial Sloan Kettering Cancer Center , University Of Texas Md Anderson Cancer Center , Cancer Center , Gilde Healthcare , Tech Dive , Medical Devices , Q Amp A ,

Calypso Enters into Agreement to Be Acquired by Novartis

Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indicationsThe acquisition of Calypso gives Novartis full rights to CALY-002, a pipeline-in-a-drug with potential in dermatology, gastro-in. ....

Noord Holland , Richard Siegel , Alain Vicari , Bernard Coulie , Head Of Immunology Research At Novartis , Goodwin Procter , Jjdc Inc , Calypso Biotech , Celiac Disease , Chief Executive Officer , Immunology Research , Inkef Capital , Gilde Healthcare , Fountain Healthcare Partners , Johnson Innovation ,

Miniature neurostimulator developer Nalu Medical nets $65M VC round

Miniature neurostimulator developer Nalu Medical nets $65M VC round
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United States , Pura Vida , Tom West , Novo Holdings , Advent Life Sciences , Nalu Team , Nalu Medical , Gilde Healthcare , Endeavor Vision , Decheng Capital , Longitude Capital , Aperture Venture ,

Nalu Medical Raises $65M in Equity Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Pura Vida , Novo Holdings , Advent Life Sciences , Nalu Medical , Gilde Healthcare , Endeavor Vision , Decheng Capital , Longitude Capital , Aperture Venture , Neurostimulation System , Nalu System , Therapy Disc , Spinal Cord Stimulation , Peripheral Nerve Stimulation ,

Noema Pharma to Present at Two Upcoming Conferences

BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE ....

San Francisco , United States , Noema Pharma , Neuroscience Innovation Forum , Panel Discussion , Exploring New Modalities , Orphan Neurological , Trigeminal Neuralgia , Tuberous Sclerosis Complex , Childhood Onset Fluency Disorder , Tourette Syndrome , Gilde Healthcare , Jeito Capital , Polaris Partners , Biotech Company , Clinical Trials , Central Nervous System , Upcoming Conferences , Clinical Development , Corporate Presentation , Globe Newswire , Sofinnova Partners ,